Thapsigargin suppresses alpha 1-acid glycoprotein secretion independently of N-glycosylation and ER stress
Thapsigargin suppresses alpha 1-acid glycoprotein secretion independently of N-glycosylation and ER stress
复制标题
Thapsigargin 抑制 α1-酸性糖蛋白分泌,与 N-糖基化和 ER 应激无关
DOI:
10.1016/j.bbrc.2021.03.017
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Iwata H.
中科院分区:
文献类型:
--
作者:
Goto N;Shibutani S;Miura N;Watanabe R;Iwata H.
Alpha-1 acid glycoprotein (AGP) is a major acute-phase protein that is involved in drug/ligand binding and regulation of immune response. In response to inflammation, AGP secretion from the liver increases, resulting in elevated concentration of plasma AGP. AGP exhibits multiple N-glycosylation sites, and thus, is highly glycosylated. Although AGP glycosylation is considered to affect its functions, the significance of AGP glycosylation for its secretion is unclear. In this study, we investigated the effects of AGP glycosylation using glycosylation-deficient mouse AGP mutants lacking one, four, or all five N-glycosylation sites. Furthermore, we examined the effects of endoplasmic reticulum (ER) stress-inducing reagents, including tunicamycin and thapsigargin, which induce ER stress in an N-glycosylation-dependent and -independent manner, respectively. Here, we found that glycosylation deficiency and ER stress induce a little or no effect on AGP secretion. Conversely, thapsigargin significantly suppressed AGP secretion in glycosylation-independent manner. These findings indicate that AGP secretion is regulated via thapsigargin-sensitive pathway that might be further controlled by the intracellular calcium concentrations.